Predictive testing for pathogenic autoimmunity: The morphological approach

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 433-442

  Kuper, C Frieke ^a   Schuurman, Henk Jan ^b   Bos Kuijpers, Marga ^a   Bloksma, Nanne ^c  

^a TNO   (Netherlands)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Granuloma; Induction of autoimmune disease; Lymphoid organs; Mononuclear cell infiltrates

Indexed keywords

AUTOIMMUNE DISEASE; CELL INFILTRATION; CONFERENCE PAPER; GRANULOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOID ORGAN; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; INFLAMMATION; LYMPHOID TISSUE; PREDICTIVE VALUE OF TESTS;

ANIMALIA;

EID: 0034653815     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00223-4     Document Type: Conference Paper

References (54)

1. Accinni L., Dixon F.J. Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome. Am. J. Pathol. 96:1979;477-492.
2. Alderuccio F., Toh B.H., Gleeson P.A., Van Driel I.R. A novel method for isolating mononuclear cells from the stomachs of mice with experimental autoimmune gastritis. Autoimmunity. 21:1995;215-221.
3. Arts J.H.E., Droge S.C.M., Bloksma N., Kuper C.F. Local lymph node activation in rats after dermal application of the sensitizers 2,4-dinitrochlorobenzene and trimellitic anhydride. Fd. Chem. Toxic. 34:1996;55-62.
4. Arts J.H.E., Kuper C.F., Spoor S.M., Bloksma N. Airway morphology and function of rats following dermal sensitization and respiratory challenge with low molecular weight chemicals. Toxicol. Appl. Pharmacol. 152:1998;66-76.
5. Augstein P., Elefanty A.G., Allison J., Harrison L.C. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes. Diabetologia. 41:1998;1381-1388.
6. Asano M., Nakane A., Kohanawa M., Minagawa T. Sequential involvement of Nk cells and CD8+ T - -cells in granuloma formation of Rhodococcus aurantiacus-infected mice. Microbiol. Immunol. 39:1995;499-507.
7. Awata T., Guberski D.L., Like A.A. Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphpenia and major histocompatibility complex class II. Endocrinology. 136:1995;5731-5735.
8. Azarollo A.M., Wood R.L., Mircheff A.K., Richters A., Olsen E., Berkowitz M., Bachmann M., Huang Z.M., Zolfagari R., Warren D.W. Androgen influence on lacrimal gland apoptosis, necrosis, and lymphocytic infiltration. Invest. Opthalmol. Vis. Sci. 40:1999;592-602.
9. Beschorner W.E., Suresch D.L., Shinozawa T., Santos G.W., Hess A.D. Thymic immunopathology after cyclosporin: effect of irradiation and age on medullary involution and recovery. Transplant. Proc. 20:1988;1072-1078.
10. Bloksma N., Kubicka-Muranyi M., Schuppe H.C., Gleichmann E., Gleichmann H. Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats. Crit. Rev. Toxicol. 25:1995;369-396.
11. Caldwell J.C., McGadey J., Kerr R., Bennett N.K., McDonald S.W. Cell recruitment to the sperm granuloma which follows vasectomy in the rat. Clin. Anat. 9:1996;302-308.
12. Chalk J.B., McCombe P.A., Smith R., Pender M.P. Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens. J. Neurol. Sci. 123:1994;154-161.
13. Cohen Tervaert J.W., Stegeman C.A., Kallenberg C.G.M. Silicon exposure and vasculitis. Curr. Opin. Rheumatol. 10:1998;12-17.
14. De Silva H.D., Van Driel I.R., La Gruta N., Toh B.H., Gleeson P.A. CD4+ T-cells, but not CD8+ T-cells, are required for the development of experimental autoimmune gastritis. Immunology. 93:1998;405-408.
15. Dixon F.J. The pathogenesis of murine systemic lupus erythematosus. Am. J. Pathol. 97:1979;10-16.
16. Dixon D., Heider K., Elwell M.R. Incidence of nonneoplastic lesions in historical control male and female Fischer-344 rats from 90-day toxicity studies. Toxicol. Pathol. 23:1995;338-348.
17. Doukas J., Mordes J.P., Swymer C., Niedzwiecki D., Mason R., Rozing J., Rossini A.A., Greiner D.L. Thymis epithelial defects and predisposition to autoimmune disease in BB rats. Am. J. Pathol. 145:1994;1517-1525.
18. Druet P., Pelletier L., Rossert J., Druet E., Hirsch F., Sapin C. Autoimmune reactions induced by metals. Kammueller M.E., Bloksma N., Seinen W. Autoimmunity and Toxicology. 1989;347-363 Elsevier, Amsterdam.
19. Duncan M.R., Berman B., Van de Water J., Boyd R.L., Wick G., Gershwin M.E. Mononuclear cells isolated from fibrotic skin lesions in avian scleroderma constitutively produce fibroblast-activating cytokines and immunoglobulin M. Int. Arch. Allergy Immunol. 107:1995;519-526.
20. Germann P.-G., Haefner D., Hanauer G., Drommer W. Incidence and severity of granulomatous pneumonia in Brown Norway (BN) rats: breeder related variations. J. Exp. Anim. Sci. 39:1998;22-33.
21. Greenwood J., Howes R., Lightman S. The blood-retina barrier in experimental autoimmune uveoretinitis. Leukocyte interactions and functional damage. Lab. Invest. 70:1994;39-52.
22. Haley P.J. Mechanisms of granulomatous lung disease from inhaled beryllium: the role of antigenicity in granuloma formation. Toxicol. Pathol. 19:1991;514-526.
23. Haley P.J., Swafford D.S., Finch G.L., Hoover M.D., Muggenburg B.A., Johnson N.F. Immunologic specificity of lymphocyte cell lines from dogs exposed to beryllium oxide. Immunopharmacol. Immunotoxicol. 19:1997;459-471.
24. Herrera P.L., Harlan D.M., Fossati L., Izui S., Huarte J., Orci L., Vassalli J.D., Vassalli P. A CD8+ T lymphocyte-mediated and CD4+ T lymphocyte-independent autoimmune diabetes of early onset in transgenic mice. Diabetologia. 37:1994;1277-1279.
25. Hinton D.M. Immunotoxicity testing applied to direct food and colour additives: US FDA 'Redbook II' guidelines. Hum. Exp. Toxicol. 14:1995;143-145.
26. Holt P.G., Britten D., Sedgwick J.D. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. Immunology. 60:1987;97-102.
27. IPCS, 1996. International Programme on Chemical Safety. Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals. Geneva, World Health Organization.
28. Iwakoshi N.N., Goldschneider I., Tausche F., Mordes J.P., Rossini A.A., Greiner D.L. High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone biobreeding rats. J. Immunol. 15:1998;5838-5858.
29. Kammueller M.E., Bloksma N., Seinen W. Autoimmunity and toxicology. Immune dysregulation induced by drugs and chemicals. Kammueller M.E., Bloksma N., Seinen W. Autoimmunity and Toxicology. 1989;3-35 Elsevier, Amsterdam.
30. Kimber I., Hilton J., Dearman R.J., Gerberick G.F., Ryan C.A., Basketter D.A., Lea L., House R.V., Ladics G.S., Loveless S.E., Hastings K.L. Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: an interlaboratory evaluation. J. Toxicol. Environ. Health. 17:1998;537-540.
31. Klinman D.M. Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J. Clin. Invest. 86:1990;1249-1254.
32. Koeter H.B.W.M. International harmonisation of immunotoxicity testing. Hum. Exp. Toxicol. 14:1995;151-154.
33. Lan H.Y., Nikolic-Paterson D.J., Mu W., Atkins R.C. Local macrophage proliferation in multinucleated giant cell and granuloma formation in experimental Goodpasture's syndrome. Am. J. Pathol. 147:1995;1214-1220.
34. Martinelli T.M., Van Driel I.R., Alderuccio F., Gleeson P.A., Toh B.H. Analysis of mononuclear cell infiltrate and cytokine production in murine autoimmune gastritis. Gastroenterology. 110:1996;1791-1802.
35. Meyers C.M., Zhang Y.K. Immunomodulatory effects of interferon-gamma on autoreactive nephritogenic T-cell clones. Kidney Int. 55:1999;1395-1406.
36. Michielsen, C.P.P.C., Leusink-Muis, A., Vos, J.G., Bloksma, N., 2000. Hexachlorobenzene-induced eosinophilic and granulomatous lung inflammation is associated with in vivo airways hyperresponsiveness in the Brown Norway rat, (submitted for publication).
37. Nabarra B., Andrianarison I. Thymus reticulum of autoimmune mice. 3. Ultrastructural study of NOD (non-obese diabetic) mouse thymus. Int. J. Exp. Pathol. 72:1991;275-287.
38. Naito M., Umeda S., Takahashi K., Shultz L.D. Macrophage differentiation and granulomatous inflammation in osteopetrotic mice (op/op) defective in the production of CSF-1. Mol. Reprod. Dev. 46:1997;85-91.
39. 2-induced glandular pathosis in the Brown Norway rat. Clin. Immunol. Immunopathol. 69:1993;272-277.
40. Richter-Reichhelm H.B., Dasenbrock C.A., Descotes G., Emmendorfer A.C., Ernst H.U., Harleman J.H., Hildebrand B., Kuttler K., Ruhl-Fehlert C.I., Schilling K., Schulte A.E., Vohr H.W. Validation of a modified 28-day rat study to evidence effects of test compounds on the immune system. Regul. Toxicol. Pharmacol. 22:1995;54-56.
41. 2-induced autoimmunity and immune suppression. Scand. J. Immunol. 48:1998;389-396.
42. Rotter B.A., Prelusky D.B. Toxicology of deoxynivalenol (vomitoxin). J. Toxicol. Environ. Health. 48:1996;1-34.
43. Rubin E., Farber J.L. Pathology. 3rd edn. 1999;Lippincott-Raven, Philadelphia, PA.
44. Schuurman H.-J., Kuper C.F. Pathology of the thymus: changes induced by xenobiotics and gene targeting. APMIS. 103:1995;481-500.
45. Schuurman H.-J., Krainc-Franken M.A.M., Kuper C.F., Van Loveren H., Vos J.G. Immune system. Haschek W.M., Rousseaux C.G. Handbook of Toxicologic Pathology. 1991;421-483 Academic Press, San Diego.
46. Shin T., kojima T., Tanuma N., Ishihara Y., Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 56:1995;171-178.
47. Slavin R.E., Swedo J.L., Brandes D., Gonzalez-Vitale J.C., Osornio-Vegas A. Extrapulmonary silicosis. A clinical, morphologic and ultrastructural study. Hum. Pathol. 16:1985;393-412.
48. Solleveld, H.A., 1981. Praomys (Mastomys) natalensis in aging research. Thesis, W.D. Meinema, Delft.
49. Stites D.P., Terr A.I., Parslow T.G. Medical Immunology. 9th edn. 1997;Appleton and Lange, Stamford, CT.
50. Terr A.I. Mechanisms of hypersensitivity. Stites D.P., Terr A.I., Parslow T.G. Medical Immunology. 9th edn:1997;376-389 Appleton and Lange, Stamford, CT.
51. The ICICIS Group Investigators, 1998. Report of validation study of assessment of direct immunotoxicity in the rat. Toxicology 125, 183-210.
52. Van de Water J., Wilson T.J., Haapanen L.A., Boyd R.L., Abplanalp H., Gershwin M.E. Ontogeny of T cell development in avian scleroderma. Clin. Immunol. Immunpathol. 56:1990;169-184.
53. Van Zwieten M.J., Zurcher C., Solleveld H.A., Hollander C.F. Pathology. Adler Ch.I.W.H., Nordin A.A. Immunological Techniques Applied to Aging Research. 1981;CRC Press, West Palm Beach, FL.
54. Winkelstein A. Immunosuppressive therapy. Stites D.P., Terr A.I., Parslow T.G. Medical Immunology. 9th edn. 1997;827-846 Appleton and Lange, Stamford, CT.